Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Gross Profit: 2019-2023

Historic Gross Profit for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to $763,000.

  • ADC Therapeutics' Gross Profit fell 98.98% to $763,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $24.1 million, marking a year-over-year decrease of 82.31%. This contributed to the annual value of $205,329 for FY2022, which is 531.32% up from last year.
  • Per ADC Therapeutics' latest filing, its Gross Profit stood at $763,000 for Q3 2023, which was down 84.19% from $4.8 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Gross Profit registered a high of $30.5 billion during Q3 2019, and its lowest value of -$77.1 billion during Q4 2019.
  • In the last 3 years, ADC Therapeutics' Gross Profit had a median value of $4.8 million in 2023 and averaged $15.6 million.
  • Data for ADC Therapeutics' Gross Profit shows a peak YoY increase of 39,048.61% (in 2021) and a maximum YoY decrease of 7,917.70% (in 2021) over the last 5 years.
  • Over the past 5 years, ADC Therapeutics' Gross Profit (Quarterly) stood at -$77.1 billion in 2019, then plummeted by 100.00% to $32,300 in 2020, then skyrocketed by 39,048.61% to $16,240 in 2021, then skyrocketed by 326.78% to $69,309 in 2022, then crashed by 98.98% to $763,000 in 2023.
  • Its Gross Profit was $763,000 in Q3 2023, compared to $4.8 million in Q2 2023 and $18.4 million in Q1 2023.